Skip to main content

MoneyWorks4Me

Prism Medico And Pharmacy informs about disclosure

26 Apr 2022 Evaluate
Pursuant to Regulation 32 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Prism Medico And Pharmacy has confirmed that there has been no deviation(s) or variation(s) in the use of the Public Issue Proceeds raised from the Initial Public Issue (IPO). Hence the Statement of Deviation(s) or Variation(s) is not applicable to the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Redington 366.60
Adani Enterprises 2705.00
Amrapali Industries 35.44
Maxgrow India 179.40
Rashi Peripheral 846.30
View more..